Why Choose Lanluma 01
02
03
Promotes improved skin tightness & textures
Next Generation PLLA technology
Suitable for face & body
• Stable for longer than 1st-Gen comparator product 1,2 • Avoids particle separation/ settlement 1,2
• Increases volume and skin quality on face & body 3 • Protocols include face, neck & décolleté, arms, hands, thighs, buttocks and abdomen 3
• Consistently successful patient results 4 • High levels of patient satisfaction evident in clinical evaluation reports 4 • Improved skin tightness and texture in 93.3% following décolleté treatment 4
• High safety rate of 0.224% 2
• Effective on cellulite 3
1. Sinclair Pharma. Data on file; 2. Sinclair Pharma. Data on file. Evidence was gathered from adverse events reports raised with Vigilance since February 2021 to end of May 2024; 3. Sinclair Pharma. Lanluma Instructions for Use; 4. Amselem M, et al. J Cosmet Dermatol 2024;00:1-10.
Features Before & After Results 1 2 3 Why Lanluma
Product Summary
Training Resources
Mode of Action
Clinical Data
Safety
MaiLi
Lanluma Ellansé Lanluma
PRODUCT COMPARISON
3
Made with FlippingBook Digital Publishing Software